Roche Holdings, Inc. Sustainability Profile
Roche Holdings, Inc., commonly referred to as Roche, is a leading global healthcare company headquartered in the United States. Founded in 1896, Roche has established a strong presence in the pharmaceutical and diagnostics industries, with significant operations across Europe, Asia, and the Americas. The company is renowned for its innovative approach to personalised medicine, focusing on oncology, immunology, and infectious diseases. Roche's core products include cutting-edge pharmaceuticals and advanced diagnostic tools, which are distinguished by their commitment to research and development. With a robust market position, Roche has achieved numerous milestones, including being a pioneer in biotechnology and maintaining a strong portfolio of blockbuster drugs. The company's dedication to improving patient outcomes solidifies its reputation as a leader in the healthcare sector.
DitchCarbon Score
How does Roche Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Roche Holdings, Inc.'s score of 37 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Roche Holdings, Inc.'s reported carbon emissions
In 2022, Roche Holdings, Inc. reported total carbon emissions of approximately 74,260 kg CO2e. This figure includes Scope 1 emissions of about 17,500 kg CO2e, while Scope 2 emissions were negligible at 0 kg CO2e. The majority of emissions, approximately 56,760 kg CO2e, were classified under Scope 3, primarily from business travel. Roche Holdings, Inc. is a current subsidiary of Roche Holding AG, which may influence its climate commitments and reporting practices. However, there are no specific reduction targets or initiatives disclosed in the available data. The company has not reported any Science-Based Targets Initiative (SBTi) reduction targets or other formal climate pledges. For 2023, Roche has indicated a CO2 intensity of 500 kg CO2e per employee for Scope 1 and 2 emissions, but detailed emissions data for this year is not provided. Looking ahead to 2025, Roche has reported a Scope 1 and 2 GHG emissions factor of 0.4 kg CO2e per employee, suggesting a focus on reducing emissions per capita. Overall, while Roche Holdings, Inc. has made some disclosures regarding its emissions, the lack of specific reduction targets and comprehensive data limits the assessment of its climate commitments.
How Carbon Intensive is Roche Holdings, Inc.'s Industry?
How Carbon Intensive is Roche Holdings, Inc.'s Location?
Roche Holdings, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Roche Holdings, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.